» Articles » PMID: 38203322

Ethyl Acetate Fraction from a . Don Extract Inhibits ɑ-MSH-Induced Melanogenesis Through the CAMP/CREB Pathway

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Jan 11
PMID 38203322
Authors
Affiliations
Soon will be listed here.
Abstract

The whitening effect of reducing skin pigmentation is one of the most important goals of cosmetics. The purpose of this study was to determine whether extract and its fractions have potential as natural skin-lightening agents. Initially, we screened various fractions of extract using an in vitro antioxidant assay. Then, the inhibitory effects of extract and its fraction on melanogenesis and the related mechanisms were investigated in B16F1 melanoma cells. The results showed that the ethyl acetate fraction (EF) from extract markedly inhibited melanin synthesis in a dose-dependent manner at non-toxic concentrations. Furthermore, EF downregulated both the protein and mRNA levels of tyrosinase, which is a specific enzyme that catalyzes the conversion of tyrosine into melanin. We also found that EF decreased the microphthalmia-associated transcription factor (MITF) at the protein and mRNA levels. EF increased the phosphorylation of ERK and suppressed the phosphorylation of JNK and p38 in ɑ-MSH-induced B16F1 cells. These results indicate that EF can regulate the MAPK pathway. In addition, EF has an anti-melanogenic effect via the downregulation of intracellular cyclic-AMP (cAMP). Nineteen major compounds of EF were identified using LC-MS/MS. Taken together, these results suggest that EF may be a potential anti-melanogenic agent for use in skin-whitening cosmetics and in topical treatments for hyperpigmentation disorders.

Citing Articles

Typha pollen extract inhibit melanogenesis via α-MSH/MC1R signaling pathway in B16 and melasma mouse model.

Zheng S, Deng R, Xie S, Huang G, Ou Z, Shen Z Arch Dermatol Res. 2025; 317(1):321.

PMID: 39890718 DOI: 10.1007/s00403-024-03752-0.


Global research trends on melasma: a bibliometric and visualized study from 2014 to 2023.

Wang L, Pang Y, Li W, He Q, Zhang X, Liu E Front Pharmacol. 2024; 15:1421499.

PMID: 39119611 PMC: 11306164. DOI: 10.3389/fphar.2024.1421499.

References
1.
Moon M, Choi B, Oh G, Pae H, Kim J, Oh H . Catalposide protects Neuro 2A cells from hydrogen peroxide-induced cytotoxicity via the expression of heme oxygenase-1. Toxicol Lett. 2003; 145(1):46-54. DOI: 10.1016/s0378-4274(03)00268-6. View

2.
Sato K, Ando R, Kobayashi H, Nishio T . 2-Ethoxybenzamide stimulates melanin synthesis in B16F1 melanoma cells via the CREB signaling pathway. Mol Cell Biochem. 2016; 423(1-2):39-52. DOI: 10.1007/s11010-016-2823-x. View

3.
Saeedi M, Eslamifar M, Khezri K . Kojic acid applications in cosmetic and pharmaceutical preparations. Biomed Pharmacother. 2018; 110:582-593. DOI: 10.1016/j.biopha.2018.12.006. View

4.
Wu L, Lin Y, Yang S, Weng Y, Tsai Y . Antimelanogenic effect of c-phycocyanin through modulation of tyrosinase expression by upregulation of ERK and downregulation of p38 MAPK signaling pathways. J Biomed Sci. 2011; 18:74. PMC: 3210093. DOI: 10.1186/1423-0127-18-74. View

5.
Pearson G, Robinson F, Beers Gibson T, Xu B, Karandikar M, Berman K . Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001; 22(2):153-83. DOI: 10.1210/edrv.22.2.0428. View